We are actively working to introduce bioidentical hormone pellet therapy in the UAE and GCC region through a clear, regulated approach to ensure patient safety and success.

Key steps in this process include:

1. Importing FDA-Regulated Pellets:
   Pellets are sourced from an FDA-regulated 503B compounding pharmacy to ensure quality and consistency.
2. FDA-Approved Insertion Devices:
   The Re3 Advanced Pellet Delivery System, an FDA-approved device, ensures that the insertion process is both safe and consistent.
3. Regulatory Advocacy:
   Our aim is to partner with the MOH, DHA, and DOH to ensure that bioidentical pellet therapy is properly regulated, preventing the use of unregulated hormone products.
4. Training & Education:
   We are in the process of establishing a training center to offer educational programs for healthcare providers. These programs will be designed to ensure that medical professionals have the necessary knowledge to safely prescribe and administer bioidentical hormone replacement therapy (BHRT). As we work through regulatory processes, our focus is on preparing healthcare providers to deliver these therapies safely and effectively, in alignment with the highest industry standards once fully authorized.
5. Medical Tourism:
   By ensuring safe, regulated practices, we aim to position the UAE as a hub for medical tourism in the MENA region, attracting patients seeking safe, effective hormone therapy.